Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02869529
What this trial is testing

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Institut Paoli-Calmettes 4,200
Not applicableEnded earlyNCT04655261
What this trial is testing

Study of Oral Venetoclax Tablets in Combination With Intravenous Obinutuzumab Injection to Assess Achievement of Best Response in Adult Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 5
Testing effectiveness (Phase 2)UnknownNCT05932173
What this trial is testing

Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies

Who this might be right for
B-Cell LeukemiaB-Cell LymphomaB-cell Tumors
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 60
Not applicableStudy completedNCT00712556
What this trial is testing

PET Study in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Not applicableStudy completedNCT00274794
What this trial is testing

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Who this might be right for
Lymphoma
The Cleveland Clinic 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT02339922
What this trial is testing

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaFollicular LymphomaLymphoplasmacytic Lymphoma+6 more
University of Washington 33
Early research (Phase 1)Study completedNCT00003970
What this trial is testing

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT02535286
What this trial is testing

Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation

Who this might be right for
Chronic Lymphocytic LeukemiaRichter Syndrome
TG Therapeutics, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT00669318
What this trial is testing

Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Mayo Clinic 41
Early research (Phase 1)Active Not RecruitingNCT02153580
What this trial is testing

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaB-Cell Prolymphocytic LeukemiaHigh Grade B-Cell Lymphoma, Not Otherwise Specified+10 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00292760
What this trial is testing

A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion

Who this might be right for
Chronic Lymphocytic Leukaemia
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT01998035
What this trial is testing

Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
Lymphoid MalignanciesLymphomaHodgkin Lymphoma+1 more
Columbia University 58
Large-scale testing (Phase 3)Study completedNCT00086580
What this trial is testing

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 335
Early research (Phase 1)Study completedNCT01886859
What this trial is testing

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent B-Cell Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more
National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Study completedNCT01313689
What this trial is testing

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT00262782
What this trial is testing

Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 877
Testing effectiveness (Phase 2)Study completedNCT00002725
What this trial is testing

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01416974
What this trial is testing

Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 13
Next Page
37